The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session.

Dominic Rose, an analyst at Intron Health, also sees shareholder activism as a possibility given GSK’s share-price ...

GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...

Shares of GSK plc (NYSE:GSK – Get Free Report) have been given an average rating of “Moderate Buy” by the ten brokerages that are presently covering the firm, Marketbeat.com reports. Seven analysts ...

Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,608, up by ₹275.75, or 11.82%, on the BSE. Brokerage firms, ...

The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals ...